Funding Opportunity: A System-Level Syndemic Approach to Improve HIV Care and Treatment for People from Racial and Ethnic Minority Groups – DEMONSTRATION SYSTEMS (HRSA-24-107)
Resource updated 07/19/2024
Resource updated 07/19/2024
Resource updated 07/19/2024
Resource updated 05/29/2024
Resource updated 05/15/2024
Resource updated 05/17/2024
Resource from the RWHAP Best Practices Compilation updated on 05/20/2024
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 07/17/2024
Hepatitis C infection resources for medical providers with a listing of HCV medication, online training modules, slide lectures, tools and calculators, and a bibliography.
Resource updated 09/20/2023
Form for clients explaining the maximum annual amount of costs they will incur for RWHAP services they receive.
Resource updated 09/19/2023
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
Resource updated 07/17/2024
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
Tool for assessing your organization’s strengths and gaps in areas that (1) are important to insurers and (2) support maximizing revenue from contracting activities.
Resource updated 10/05/2023
Insights to ADAP procedures for seeking rebates when a prescription is filled by another 340B entity pharmacy.
Resource updated 03/05/2024